Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3557)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
24,973
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
25,063
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
53
Price
$332.64
Total Value
$17.63K
Shares Held After
64,273
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
129
Price
$331.93
Total Value
$42.82K
Shares Held After
64,326
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
112
Price
$330.85
Total Value
$37.06K
Shares Held After
64,455
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
234
Price
$329.71
Total Value
$77.15K
Shares Held After
64,567
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
138
Price
$328.71
Total Value
$45.36K
Shares Held After
64,801
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
454
Price
$327.67
Total Value
$148.76K
Shares Held After
64,939
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
541
Price
$326.81
Total Value
$176.80K
Shares Held After
65,393
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
356
Price
$325.63
Total Value
$115.92K
Shares Held After
65,934
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
124
Price
$324.65
Total Value
$40.26K
Shares Held After
66,290
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Poulton Jeffrey V. — EVP, Chief Financial Officer
Shares
65
Price
$323.62
Total Value
$21.04K
Shares Held After
66,414
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
42
Price
$332.64
Total Value
$13.97K
Shares Held After
25,181
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
101
Price
$331.93
Total Value
$33.52K
Shares Held After
25,223
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
87
Price
$330.85
Total Value
$28.78K
Shares Held After
25,324
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
182
Price
$329.71
Total Value
$60.01K
Shares Held After
25,411
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
107
Price
$328.71
Total Value
$35.17K
Shares Held After
25,593
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
353
Price
$327.67
Total Value
$115.67K
Shares Held After
25,700
% of Holdings
1.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
421
Price
$326.81
Total Value
$137.59K
Shares Held After
26,053
% of Holdings
1.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
277
Price
$325.63
Total Value
$90.20K
Shares Held After
26,474
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
97
Price
$324.65
Total Value
$31.49K
Shares Held After
26,751
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Garg Pushkal — EVP Chief R&D
Shares
50
Price
$323.62
Total Value
$16.18K
Shares Held After
26,848
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
578
Price
$70.46
Total Value
$40.73K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
15,322
Price
$69.80
Total Value
$1.07M
Shares Held After
768,358
% of Holdings
2.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,100
Price
$69.20
Total Value
$283.71K
Shares Held After
783,680
% of Holdings
0.5%
Vanda Pharmaceuticals Inc. (VNDA)
Moran Kevin Patrick — SVP, CFO & Treasurer
Shares
42,442
Price
$8.27
Total Value
$350.82K
Shares Held After
411,380
% of Holdings
9.4%
Vanda Pharmaceuticals Inc. (VNDA)
Williams Timothy — SVP & General Counsel
Shares
42,434
Price
$8.27
Total Value
$350.76K
Shares Held After
377,450
% of Holdings
10.1%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
66,363
Price
$28.14
Total Value
$1.87M
Shares Held After
793
% of Holdings
98.8%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
4,090
Price
$27.51
Total Value
$112.50K
Shares Held After
67,156
% of Holdings
5.7%
Vanda Pharmaceuticals Inc. (VNDA)
Wijkstrom Joakim — SVP, Chief Marketing Officer
Shares
30,800
Price
$8.27
Total Value
$254.59K
Shares Held After
333,469
% of Holdings
8.5%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
3,048
Price
$89.66
Total Value
$273.28K
Shares Held After
122,029
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
1,055
Price
$88.50
Total Value
$93.37K
Shares Held After
125,077
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
1,510
Price
$87.75
Total Value
$132.50K
Shares Held After
126,132
% of Holdings
1.2%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,107
Price
$89.66
Total Value
$99.25K
Shares Held After
77,729
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
383
Price
$88.50
Total Value
$33.90K
Shares Held After
78,836
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
549
Price
$87.75
Total Value
$48.18K
Shares Held After
79,219
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
4,113
Price
$89.66
Total Value
$368.76K
Shares Held After
237,483
% of Holdings
1.7%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,424
Price
$88.50
Total Value
$126.02K
Shares Held After
241,596
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
2,039
Price
$87.75
Total Value
$178.92K
Shares Held After
243,020
% of Holdings
0.8%
Annexon, Inc. (ANNX)
Overdorf Michael — EVP & CHIEF BUSINESS OFFICER
Shares
4,339
Price
$5.42
Total Value
$23.52K
Shares Held After
182,625
% of Holdings
2.3%
Annexon, Inc. (ANNX)
Yednock Ted — EVP & CHIEF INNOVATION OFFICER
Shares
5,566
Price
$5.42
Total Value
$30.17K
Shares Held After
154,161
% of Holdings
3.5%
Annexon, Inc. (ANNX)
Dananberg Jamie — CHIEF MEDICAL OFFICER
Shares
5,820
Price
$5.43
Total Value
$31.60K
Shares Held After
123,582
% of Holdings
4.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,052
Price
$90.13
Total Value
$905.99K
Shares Held After
675,341
% of Holdings
1.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
71,814
Price
$90.13
Total Value
$6.47M
Shares Held After
3,902,667
% of Holdings
1.8%
uniQure N.V. (QURE)
Potts Jeannette — Chief Legal Officer
Shares
8,578
Price
$9.95
Total Value
$85.35K
Shares Held After
106,495
% of Holdings
7.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
29,282
Price
$14.48
Total Value
$424.12K
Shares Held After
3,334,683
% of Holdings
0.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
7,909
Price
$14.52
Total Value
$114.85K
Shares Held After
165,638
% of Holdings
4.6%
Annexon, Inc. (ANNX)
Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER
Shares
5,565
Price
$5.42
Total Value
$30.16K
Shares Held After
170,700
% of Holdings
3.2%
Annexon, Inc. (ANNX)
ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER
Shares
5,894
Price
$5.43
Total Value
$32.00K
Shares Held After
180,093
% of Holdings
3.2%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
29,282
Price
$14.47
Total Value
$423.76K
Shares Held After
3,334,616
% of Holdings
0.9%
Showing 1151–1200 of 3557 transactions (page 24 of 72)